Evidence map›Paper›PMID 42270905›Full record

ArticleNPJ digital medicine2026

Noninvasive PPROM risk stratification with explainable AI using routine antenatal CRP and albumin.

Shidong Tan, Sihan Wu, Shengnan Wu, Yicheng Zhou, Yamin Li, Hang Su, Shujian Zhang, Yao Xu, Xiaoying He, Yanqiang Han and 3 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shidong Tan *Clinical and Translational Research Center, Department of Integrated Traditional Chinese Medicine (TCM) and Western Medicine, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Sihan Wu *School of Computer Science, Hubei University, Wuhan, China.
Shengnan Wu *Clinical and Translational Research Center, Department of Integrated Traditional Chinese Medicine (TCM) and Western Medicine, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Yicheng ZhouClinical and Translational Research Center, Department of Integrated Traditional Chinese Medicine (TCM) and Western Medicine, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Yamin LiSchool of Computer Science, Hubei University, Wuhan, China.
Hang SuSchool of Computer Science, Hubei University, Wuhan, China.
Shujian ZhangSchool of Computer Science, Hubei University, Wuhan, China.
Yao XuClinical and Translational Research Center, Department of Integrated Traditional Chinese Medicine (TCM) and Western Medicine, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.
Xiaoying HeClinical and Translational Research Center, Department of Integrated Traditional Chinese Medicine (TCM) and Western Medicine, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China. hexiaoying@51mch.com.
Yanqiang HanSchool of Computer Science, Hubei University, Wuhan, China. hanyanqiang@sjtu.edu.cn.
Liping JinClinical and Translational Research Center, Department of Integrated Traditional Chinese Medicine (TCM) and Western Medicine, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China. jinlp01@163.com.
Jinjin LiSchool of Computer Science, Hubei University, Wuhan, China. lijinjin@sjtu.edu.cn.
Zhiyun WeiClinical and Translational Research Center, Department of Integrated Traditional Chinese Medicine (TCM) and Western Medicine, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China. zhiyun_wei@163.com.

Funding

Advanced Materials-National Science and Technology Major Project 2024ZD0607400Major Projects of Special Development Funds in Zhangjiang National Independent Innovation Demonstration Zone, Shanghai ZJ2025-ZD-023National Key Research and Development Program of China 2022YFC2702204National Key Research and Development Program of China 2022YFC2704702National Natural Science Foundation of China 32301040National Natural Science Foundation of China 82271701Science and Technology Cooperation Program of Shanghai Jiao Tong University in Inner Mongolia Autonomous Region-Action Plan of Shanghai Jiao Tong University for "Revitalizing Inner Mongolia through Science and Technology" 2025XYJG0001-01-07Shanghai Municipal Health Commission 2024QN065Shanghai Pudong New Area Health Commission Project PW2022D-05Shanghai Science and Technology Project 23JC1402300Shanghai Science and Technology Project 23ZR1450400Shenkang Technology standardization management and promotion project SHDC22023204
6 · The paper itself

Abstract

Premature rupture of membranes (PROM) and preterm PROM (PPROM) are significant obstetric complications, affecting 10-20% and 3% of pregnancies globally and constituting a major cause of preterm birth and neonatal morbidity. While intrauterine infection is a key underlying driver, timely identification of high-risk cases remains a clinical challenge. We developed a noninvasive artificial intelligence (AI) predictive framework using a large-scale dataset of 114,601 antenatal laboratory and ultrasound measurements. Our multimodal model integrated longitudinal clinical measures, including maternal demographics, laboratory results, and ultrasound data. The optimized XGBoost algorithm achieved high performance (AUC: 0.952) and identified elevated C-reactive protein (CRP) and decreased albumin levels in late pregnancy as top features, underscoring the critical roles of inflammation and oxidative stress. SHAP analysis ensured interpretability, unveiling dynamic risk patterns across gestation. This AI-driven approach provides a precise, noninvasive tool for late-gestation PPROM risk stratification, paving the way for translation into precision obstetric care.

Identifiers

PMID42270905
PMCPMC13598096

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.